Surgical Stapling Devices Market Size, Share, Growth Opportunities, Industry Trends and Forecast Report 2026–2034

Surgical Stapling Devices Market Overview Analysis By Fortune Business Insights Analysis
Market Summary
According to Fortune Business Insights: The global surgical stapling devices market size was valued at USD 6.50 billion in 2025 and is projected to grow from USD 7.20 billion in 2026 to USD 16.26 billion by 2034, exhibiting a CAGR of 10.73% during the forecast period. North America dominated the surgical stapling devices market with a market share of 45.37% in 2025. Surgical staplers close wounds and incisions after surgery, using staples made of titanium, plastic, or polylactide-polyglycolide copolymer, the last used mainly in plastic surgery to reduce scarring. North America led the market with a 45.37% share in 2018.
Key Market Trends
Powered and disposable staplers are gaining adoption, and surgery is shifting toward laparoscopic techniques. Manufacturers are launching devices with smaller diameters, adjustable knob sizes and angles, and lower misfire rates. Automated robotic surgery is also supporting powered stapler growth.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101593
Key Market Drivers
Technological advances in staplers and staples, rising surgical volumes, and growing chronic disease prevalence, including bariatric surgery demand, drive the market. Stapling offers advantages over traditional suturing, and the rise in laparoscopic procedures adds momentum through smaller incisions, shorter hospital stays, and lower costs. Powered staplers reduce closure time, blood loss, and mechanical pressure on tissue, and rising awareness in untapped markets adds further growth.
Market Restraints
The closest equivalent is the April 2019 U.S. FDA reclassification of staplers used for internal incision closure, prompted by increased adverse events. Reusable devices also face higher infection risk and slower adoption in established markets, and a shortage of skilled workers holds back growth in the Middle East and Africa.
Market Opportunities
Untapped markets with growing awareness offer room to expand, as does emerging-market expansion by Chinese manufacturers entering India.
Segmentation Analysis
By product type, manual staplers are expected to keep the largest share, while powered staplers are expected to grow faster. By type, disposable staplers are expected to grow faster, while reusable devices remain more common in emerging nations. By application, general surgery is projected to generate the highest revenue, with gynecology holding a significant share in 2018, followed by urology. By surgery type, open surgery led in 2018, while laparoscopic surgery is expected to have the highest CAGR. By end user, hospitals dominated in 2018 and are expected to grow fastest over the following six to seven years, with specialty clinics second.
Regional Outlook
North America led the market with USD 980.3 million in 2018, a 45.37% share, driven by laparoscopic staplers, powered devices, and robotic surgery.
Asia Pacific is expected to post the highest value growth, with China and India as key markets. Europe is expected to see significant growth, with Germany and the U.K. cited for favorable policies.
Latin America is described as having high value growth relative to North America and Europe, while the Middle East and Africa is expected to grow slowest because of skilled-workforce shortages and technology gaps.
Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/101593
Competitive Landscape
The market is highly consolidated: Medtronic and Johnson & Johnson together held more than 70% of revenue in 2018, with Medtronic leading. Other key companies include 3M, Smith & Nephew, B. Braun Melsungen AG, Purple Surgical, Intuitive Surgical, AesDex LLC, Becton Dickinson and Company, and Conmed Corporation.
In September 2018, Intuitive Surgical received U.S. FDA approval for SureForm 60, a disposable, fully wristed minimally invasive stapler.
In April 2019, the FDA reclassified surgical staplers used for internal incision closure because of increased adverse events.
What’s Driving Japan’s Market? Discover the Latest Surgical Stapling Devices Market Insights




Comments